Table 1 Clinical feature of patients with gastric duplications
From: Clinical features of gastric duplications: evidence from primary case reports and published data
| Literature-based patients (n = 311) | Two-centers patients (n = 8) | All included patients (n = 319) | |
|---|---|---|---|
| Sex | Valid = 293 | Valid = 8 | Valid = 301 |
| Male | 139 (47.44%) | 2 (2/8) | 141 (46.84%) |
| Age (years) | Valid = 305 | Valid = 8 | Valid = 313 |
| Range | 0–82 | 1–55 | 0–82 |
| Mean (SD) | 20.77 (23.15) | 30.63 (20.82) | 21.02 (23.10) |
| Type | Valid = 239 | Valid = 8 | Valid = 247 |
| Cystic | 207 (86.61%) | 8(8/8) | 215 (87.04%) |
| Tubular | 32 (13.39) | 0(0/8) | 32 (12.96%) |
| Sites | Valid = 264 | Valid = 8 | Valid = 272 |
| Greater curvature | 142 (53.79%) | 3 (3/8) | 145 (53.30%) |
| Lesser curvature | 22 (8.33%) | 3 (3/8) | 25 (9.20%) |
| Cardia | 18 (6.82%) | 0 (0/8) | 18 (6.60%) |
| Pylorus | 47 (17.80%) | 1 (1/8) | 48 (17.65%) |
| AW | 5 (1.89%) | 1 (1/8) | 6 (2.20%) |
| PW | 30 (11.36%) | 0 (0/8) | 30 (11.00%) |
| Other anomalies | Valid = 85 | Valid = 0 | Valid = 85 |
| Ectopic pancreas | 33 (38.82%) | – | 33 (38.82%) |
| Other sites duplications | 14 (16.47%) | – | 14 (16.47%) |
| Pulmonary sequestration | 6 (7.06%) | – | 6 (7.06%) |
| Congenital heart disease | 6 (7.06%) | – | 6 (7.06%) |
| Vertebral abnormalities | 4 (4.71%) | – | 4 (4.71%) |
| Other pancreas anomalies | 12 (14.12%) | – | 12 (14.12%) |
| Other anomalies | 11 (12.94%) | – | 11 (12.94%) |
| Presentation | Valid = 289 | Valid = 8 | Valid = 297 |
| Symptomatic | 228 (78.89%) | 3 (3/8) | 231 (77.78%) |
| Abdominal pain | 105 (46.05%) | 0 (0/3) | 105 (45.45%) |
| Vomiting | 105 (45.45%) | 0 (0/3) | 105 (45.45%) |
| Abdominal distension | 17 (7.46%) | 1 (1/3) | 18 (7.79%) |
| Gastrointestinal hemorrhage | 31 (13.59%) | 0 (0/3) | 31 (13.42%) |
| Fever | 15 (6.58%) | 0 (0/3) | 15 (6.49%) |
| Weight loss | 23 (10.09%) | 0 (0/3) | 23 (9.96%) |
| Others | 19 (8.33%) | 2 (2/3) | 21 (9.09%) |
| Asymptomatic | 61 (21.11%) | 5 (5/8) | 66 (22.22%) |
| Treatment strategy | Valid = 272 | Valid = 8 | Valid = 280 |
| Surgery | 256 (94.12%) | 8 (8/8) | 264 (94.29%) |
| Local resection (LR) | 181 (70.70%) | 6 (6/8) | 187 (70.83%) |
| Partial gastrectomy (PG) | 63 (24.61%) | 2 (2/8) | 65 (24.62%) |
| Radical resection (RR) | 10 (3.91%) | 0(0/8) | 10 (3.79%) |
| LR + RR | 2 (0.78%) | 0(0/8) | 2 (0.76%) |
| Conservative treatment | 16 (5.88%) | 0 (0/8) | 16 (5.71%) |
| Follow-up | |||
| Duration (month) | Valid = 75 | Valid = 2 | Valid = 77 |
| Range | 1–120 | 6–18 | 1–120 |
| Mean (SD) | 17.51 (19.44) | 12 (8.49) | 17.36 (19.23) |
| Outcomes | Valid = 75 | Valid = 2 | Valid = 77 |
| Recurrence | 1 (1.33%) | 0 (0/2) | 1 (1.30%) |
| Metastasis | 5 (6.67%) | 0 (0/2) | 5 (6.49%) |
| ANED | 61 (81.33%) | 2 (2/2) | 63 (81.82%) |
| AWD | 3 (4.00%) | 0 (0/2) | 3 (3.90%) |
| DOD | 5 (6.67%) | 0 (0/2) | 5 (6.49%) |